世界のクローン病市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Crohn's Disease Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1653 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、クローン病のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手術、薬物療法）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・クローン病の市場動向 ・企業の競争状況、市場シェア ・クローン病の種類別市場規模（手術、薬物療法） ・クローン病の用途別市場規模（病院、外来手術センター、その他） ・クローン病の北米市場規模2016-2027（アメリカ、カナダ） ・クローン病のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・クローン病のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・クローン病の中南米市場規模2016-2027（メキシコ、ブラジル） ・クローン病の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbvie、Amgen、Cambridge Antibody Technology、Janssen Biotech、Pfizer、Tillotts Pharma、Johnson & Johnson、Boehringer Ingelheim） ・結論

Crohn’s disease refers to long term inflammatory bowel disease, which causes inflammation of the lining of the digestive tract. It affects the large and small intestine and is generally diagnosed in persons within the age group of 20-29. It can have severe or acute outcomes. Signs and symptoms of Crohn’s disease develop slowly and gradually. Some of the common symptoms of this disease include abdominal pain and cramping, fever, fatigue, diarrhea, blood in stools, appetite and weight loss. Inflammation of skin, joints, and eyes, inflammation of the liver or bile duct, and delayed sexual development in children are some other symptoms associated with severe Crohn’s disease.
Rising number of drug therapies for Crohn’s disease and increasing demand for better diagnostics and treatment options for the auto-immune disease are some of the key factors driving the growth of the global Crohn’s disease market. In addition, rise in the number of patients suffering from auto-immune disorders in developing countries and increasing government initiatives for improving health care infrastructure are fueling the growth of the global Crohn’s disease market. However, less awareness among people about the disease is also restraining the growth of the market. Patent expiry of various useful drugs, such as remicade and humira, is also impeding the growth of the market.

Market Analysis and Insights: Global Crohn’s Disease Market
The global Crohn’s Disease market size is projected to reach US$ 10700 million by 2026, from US$ 8635.6 million in 2019, at a CAGR of 3.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Crohn’s Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Crohn’s Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Crohn’s Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Crohn’s Disease market.

Global Crohn’s Disease Scope and Market Size
Crohn’s Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Crohn’s Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Surgery
Drug Therapy

Segment by Application
Hospitals
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbvie
Amgen
Cambridge Antibody Technology
Janssen Biotech
Pfizer
Tillotts Pharma
Johnson & Johnson
Boehringer Ingelheim

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Crohn’s Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Drug Therapy
1.3 Market by Application
1.3.1 Global Crohn’s Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Crohn’s Disease Market Perspective (2016-2027)
2.2 Crohn’s Disease Growth Trends by Regions
2.2.1 Crohn’s Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Crohn’s Disease Historic Market Share by Regions (2016-2021)
2.2.3 Crohn’s Disease Forecasted Market Size by Regions (2022-2027)
2.3 Crohn’s Disease Industry Dynamic
2.3.1 Crohn’s Disease Market Trends
2.3.2 Crohn’s Disease Market Drivers
2.3.3 Crohn’s Disease Market Challenges
2.3.4 Crohn’s Disease Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Crohn’s Disease Players by Revenue
3.1.1 Global Top Crohn’s Disease Players by Revenue (2016-2021)
3.1.2 Global Crohn’s Disease Revenue Market Share by Players (2016-2021)
3.2 Global Crohn’s Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Crohn’s Disease Revenue
3.4 Global Crohn’s Disease Market Concentration Ratio
3.4.1 Global Crohn’s Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Crohn’s Disease Revenue in 2020
3.5 Crohn’s Disease Key Players Head office and Area Served
3.6 Key Players Crohn’s Disease Product Solution and Service
3.7 Date of Enter into Crohn’s Disease Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Crohn’s Disease Breakdown Data by Type
4.1 Global Crohn’s Disease Historic Market Size by Type (2016-2021)
4.2 Global Crohn’s Disease Forecasted Market Size by Type (2022-2027)

5 Crohn’s Disease Breakdown Data by Application
5.1 Global Crohn’s Disease Historic Market Size by Application (2016-2021)
5.2 Global Crohn’s Disease Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Crohn’s Disease Market Size (2016-2027)
6.2 North America Crohn’s Disease Market Size by Type
6.2.1 North America Crohn’s Disease Market Size by Type (2016-2021)
6.2.2 North America Crohn’s Disease Market Size by Type (2022-2027)
6.2.3 North America Crohn’s Disease Market Size by Type (2016-2027)
6.3 North America Crohn’s Disease Market Size by Application
6.3.1 North America Crohn’s Disease Market Size by Application (2016-2021)
6.3.2 North America Crohn’s Disease Market Size by Application (2022-2027)
6.3.3 North America Crohn’s Disease Market Size by Application (2016-2027)
6.4 North America Crohn’s Disease Market Size by Country
6.4.1 North America Crohn’s Disease Market Size by Country (2016-2021)
6.4.2 North America Crohn’s Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Crohn’s Disease Market Size (2016-2027)
7.2 Europe Crohn’s Disease Market Size by Type
7.2.1 Europe Crohn’s Disease Market Size by Type (2016-2021)
7.2.2 Europe Crohn’s Disease Market Size by Type (2022-2027)
7.2.3 Europe Crohn’s Disease Market Size by Type (2016-2027)
7.3 Europe Crohn’s Disease Market Size by Application
7.3.1 Europe Crohn’s Disease Market Size by Application (2016-2021)
7.3.2 Europe Crohn’s Disease Market Size by Application (2022-2027)
7.3.3 Europe Crohn’s Disease Market Size by Application (2016-2027)
7.4 Europe Crohn’s Disease Market Size by Country
7.4.1 Europe Crohn’s Disease Market Size by Country (2016-2021)
7.4.2 Europe Crohn’s Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Crohn’s Disease Market Size (2016-2027)
8.2 Asia-Pacific Crohn’s Disease Market Size by Type
8.2.1 Asia-Pacific Crohn’s Disease Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Crohn’s Disease Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Crohn’s Disease Market Size by Type (2016-2027)
8.3 Asia-Pacific Crohn’s Disease Market Size by Application
8.3.1 Asia-Pacific Crohn’s Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Crohn’s Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Crohn’s Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific Crohn’s Disease Market Size by Region
8.4.1 Asia-Pacific Crohn’s Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Crohn’s Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Crohn’s Disease Market Size (2016-2027)
9.2 Latin America Crohn’s Disease Market Size by Type
9.2.1 Latin America Crohn’s Disease Market Size by Type (2016-2021)
9.2.2 Latin America Crohn’s Disease Market Size by Type (2022-2027)
9.2.3 Latin America Crohn’s Disease Market Size by Type (2016-2027)
9.3 Latin America Crohn’s Disease Market Size by Application
9.3.1 Latin America Crohn’s Disease Market Size by Application (2016-2021)
9.3.2 Latin America Crohn’s Disease Market Size by Application (2022-2027)
9.3.3 Latin America Crohn’s Disease Market Size by Application (2016-2027)
9.4 Latin America Crohn’s Disease Market Size by Country
9.4.1 Latin America Crohn’s Disease Market Size by Country (2016-2021)
9.4.2 Latin America Crohn’s Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Crohn’s Disease Market Size (2016-2027)
10.2 Middle East & Africa Crohn’s Disease Market Size by Type
10.2.1 Middle East & Africa Crohn’s Disease Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Crohn’s Disease Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Crohn’s Disease Market Size by Type (2016-2027)
10.3 Middle East & Africa Crohn’s Disease Market Size by Application
10.3.1 Middle East & Africa Crohn’s Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Crohn’s Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Crohn’s Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa Crohn’s Disease Market Size by Country
10.4.1 Middle East & Africa Crohn’s Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Crohn’s Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Details
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Crohn’s Disease Introduction
11.1.4 Abbvie Revenue in Crohn’s Disease Business (2016-2021)
11.1.5 Abbvie Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Crohn’s Disease Introduction
11.2.4 Amgen Revenue in Crohn’s Disease Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Cambridge Antibody Technology
11.3.1 Cambridge Antibody Technology Company Details
11.3.2 Cambridge Antibody Technology Business Overview
11.3.3 Cambridge Antibody Technology Crohn’s Disease Introduction
11.3.4 Cambridge Antibody Technology Revenue in Crohn’s Disease Business (2016-2021)
11.3.5 Cambridge Antibody Technology Recent Development
11.4 Janssen Biotech
11.4.1 Janssen Biotech Company Details
11.4.2 Janssen Biotech Business Overview
11.4.3 Janssen Biotech Crohn’s Disease Introduction
11.4.4 Janssen Biotech Revenue in Crohn’s Disease Business (2016-2021)
11.4.5 Janssen Biotech Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Crohn’s Disease Introduction
11.5.4 Pfizer Revenue in Crohn’s Disease Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Tillotts Pharma
11.6.1 Tillotts Pharma Company Details
11.6.2 Tillotts Pharma Business Overview
11.6.3 Tillotts Pharma Crohn’s Disease Introduction
11.6.4 Tillotts Pharma Revenue in Crohn’s Disease Business (2016-2021)
11.6.5 Tillotts Pharma Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Crohn’s Disease Introduction
11.7.4 Johnson & Johnson Revenue in Crohn’s Disease Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Crohn’s Disease Introduction
11.8.4 Boehringer Ingelheim Revenue in Crohn’s Disease Business (2016-2021)
11.8.5 Boehringer Ingelheim Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Crohn's Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgery
Table 3. Key Players of Drug Therapy
Table 4. Global Crohn's Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Crohn's Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Crohn's Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Crohn's Disease Market Share by Regions (2016-2021)
Table 8. Global Crohn's Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Crohn's Disease Market Share by Regions (2022-2027)
Table 10. Crohn's Disease Market Trends
Table 11. Crohn's Disease Market Drivers
Table 12. Crohn's Disease Market Challenges
Table 13. Crohn's Disease Market Restraints
Table 14. Global Crohn's Disease Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Crohn's Disease Market Share by Players (2016-2021)
Table 16. Global Top Crohn's Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crohn's Disease as of 2020)
Table 17. Ranking of Global Top Crohn's Disease Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Crohn's Disease Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Crohn's Disease Product Solution and Service
Table 21. Date of Enter into Crohn's Disease Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Crohn's Disease Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Crohn's Disease Revenue Market Share by Type (2016-2021)
Table 25. Global Crohn's Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Crohn's Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Crohn's Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Crohn's Disease Revenue Market Share by Application (2016-2021)
Table 29. Global Crohn's Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Crohn's Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Crohn's Disease Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Crohn's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Crohn's Disease Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Crohn's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Crohn's Disease Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Crohn's Disease Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Crohn's Disease Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Crohn's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Crohn's Disease Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Crohn's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Crohn's Disease Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Crohn's Disease Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Crohn's Disease Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Crohn's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Crohn's Disease Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Crohn's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Crohn's Disease Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Crohn's Disease Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Crohn's Disease Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Crohn's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Crohn's Disease Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Crohn's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Crohn's Disease Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Crohn's Disease Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Crohn's Disease Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Crohn's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Crohn's Disease Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Crohn's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Crohn's Disease Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Crohn's Disease Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbvie Company Details
Table 62. Abbvie Business Overview
Table 63. Abbvie Crohn's Disease Product
Table 64. Abbvie Revenue in Crohn's Disease Business (2016-2021) & (US$ Million)
Table 65. Abbvie Recent Development
Table 66. Amgen Company Details
Table 67. Amgen Business Overview
Table 68. Amgen Crohn's Disease Product
Table 69. Amgen Revenue in Crohn's Disease Business (2016-2021) & (US$ Million)
Table 70. Amgen Recent Development
Table 71. Cambridge Antibody Technology Company Details
Table 72. Cambridge Antibody Technology Business Overview
Table 73. Cambridge Antibody Technology Crohn's Disease Product
Table 74. Cambridge Antibody Technology Revenue in Crohn's Disease Business (2016-2021) & (US$ Million)
Table 75. Cambridge Antibody Technology Recent Development
Table 76. Janssen Biotech Company Details
Table 77. Janssen Biotech Business Overview
Table 78. Janssen Biotech Crohn's Disease Product
Table 79. Janssen Biotech Revenue in Crohn's Disease Business (2016-2021) & (US$ Million)
Table 80. Janssen Biotech Recent Development
Table 81. Pfizer Company Details
Table 82. Pfizer Business Overview
Table 83. Pfizer Crohn's Disease Product
Table 84. Pfizer Revenue in Crohn's Disease Business (2016-2021) & (US$ Million)
Table 85. Pfizer Recent Development
Table 86. Tillotts Pharma Company Details
Table 87. Tillotts Pharma Business Overview
Table 88. Tillotts Pharma Crohn's Disease Product
Table 89. Tillotts Pharma Revenue in Crohn's Disease Business (2016-2021) & (US$ Million)
Table 90. Tillotts Pharma Recent Development
Table 91. Johnson & Johnson Company Details
Table 92. Johnson & Johnson Business Overview
Table 93. Johnson & Johnson Crohn's Disease Product
Table 94. Johnson & Johnson Revenue in Crohn's Disease Business (2016-2021) & (US$ Million)
Table 95. Johnson & Johnson Recent Development
Table 96. Boehringer Ingelheim Company Details
Table 97. Boehringer Ingelheim Business Overview
Table 98. Boehringer Ingelheim Revenue in Crohn's Disease Business (2016-2021) & (US$ Million)
Table 99. Boehringer Ingelheim Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Crohn's Disease Market Share by Type: 2020 VS 2027
Figure 2. Surgery Features
Figure 3. Drug Therapy Features
Figure 4. Global Crohn's Disease Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Others Case Studies
Figure 8. Crohn's Disease Report Years Considered
Figure 9. Global Crohn's Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Crohn's Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Crohn's Disease Market Share by Regions: 2020 VS 2027
Figure 12. Global Crohn's Disease Market Share by Regions (2022-2027)
Figure 13. Global Crohn's Disease Market Share by Players in 2020
Figure 14. Global Top Crohn's Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crohn's Disease as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Crohn's Disease Revenue in 2020
Figure 16. Global Crohn's Disease Revenue Market Share by Type (2016-2021)
Figure 17. Global Crohn's Disease Revenue Market Share by Type (2022-2027)
Figure 18. North America Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Crohn's Disease Market Share by Type (2016-2027)
Figure 20. North America Crohn's Disease Market Share by Application (2016-2027)
Figure 21. North America Crohn's Disease Market Share by Country (2016-2027)
Figure 22. United States Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Crohn's Disease Market Share by Type (2016-2027)
Figure 26. Europe Crohn's Disease Market Share by Application (2016-2027)
Figure 27. Europe Crohn's Disease Market Share by Country (2016-2027)
Figure 28. Germany Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Crohn's Disease Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Crohn's Disease Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Crohn's Disease Market Share by Region (2016-2027)
Figure 38. China Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Crohn's Disease Market Share by Type (2016-2027)
Figure 46. Latin America Crohn's Disease Market Share by Application (2016-2027)
Figure 47. Latin America Crohn's Disease Market Share by Country (2016-2027)
Figure 48. Mexico Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Crohn's Disease Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Crohn's Disease Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Crohn's Disease Market Share by Country (2016-2027)
Figure 54. Turkey Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Crohn's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbvie Revenue Growth Rate in Crohn's Disease Business (2016-2021)
Figure 58. Amgen Revenue Growth Rate in Crohn's Disease Business (2016-2021)
Figure 59. Cambridge Antibody Technology Revenue Growth Rate in Crohn's Disease Business (2016-2021)
Figure 60. Janssen Biotech Revenue Growth Rate in Crohn's Disease Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Crohn's Disease Business (2016-2021)
Figure 62. Tillotts Pharma Revenue Growth Rate in Crohn's Disease Business (2016-2021)
Figure 63. Johnson & Johnson Revenue Growth Rate in Crohn's Disease Business (2016-2021)
Figure 64. Boehringer Ingelheim Revenue Growth Rate in Crohn's Disease Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---